[The role of PSA in prostatic adenocarcinoma].
The introduction of new tumours markers poses the problem of assessing their real predictive power and of considering all their possible uses. The following questions have been examined: 1) is PSA able to offer early diagnosis of prostate Ca 2) is there a relationship between cancer grading and PSA levels? 3) is it possible to use PSA to monitor patients under treatment? 4) can PSA predict the existence of bone metastasis?
Divisione di Urologia, U.S.S.L. n. 22, Ospedale Civile, Sondrio.
G P
GP
Manca
D000135:Acid Phosphatase / Q000097:blood; D000230:Adenocarcinoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic; D009367:Neoplasm Staging; D011379:Prognosis; D011467:Prostate / Q000201:enzymology; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011863:Radioimmunoassay
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen
Ruolo della PSA nell'adenocarcinoma della prostata.